Characterization of Bacillus probiotics available for human use
about
Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot studyProbiotics under the regulatory microscope.Screening for bacillus isolates in the broiler gastrointestinal tract.Characterization of Bacillus mojavensis KJS-3 for industrial applications.Protective effect of the probiotic Saccharomyces boulardii in Toxocara canis infection is not due to direct action on the larvaeThe first 1000 cultured species of the human gastrointestinal microbiota.DNA polymorphisms and biocontrol of Bacillus antagonistic to citrus bacterial canker with indication of the interference of phyllosphere biofilmsCharacterization of Bacillus spp. strains for use as probiotic additives in pig feed.Safety assessment of probiotics for human use.The intestinal life cycle of Bacillus subtilis and close relativesConcerted action of sphingomyelinase and non-hemolytic enterotoxin in pathogenic Bacillus cereus.Food-producing animals and their health in relation to human health.Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella.Bacillus clausii for Prevention of Late-onset Sepsis in Preterm Infants: A Randomized Controlled Trial.Effect of Bacillus subtilis CGMCC 1.1086 on the growth performance and intestinal microbiota of broilers.Evaluation of a Bacillus direct-fed microbial candidate on digesta viscosity, bacterial translocation, microbiota composition and bone mineralisation in broiler chickens fed on a rye-based diet.Massive horizontal gene transfer, strictly vertical inheritance and ancient duplications differentially shape the evolution of Bacillus cereus enterotoxin operons hbl, cytK and nhe.Functional Properties of Filamentous Fungi Isolated from the Indonesian Fermented Dried Cassava, with Particular Application on Poultry.Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancerComplete Genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, Two Phylogenetically Distinct Probiotics.Bacillus clausii and gut homeostasis: state of the art and future perspectives.Synergistic effects of probiotic Leuconostoc mesenteroides and Bacillus subtilis in malted ragi (Eleucine corocana) food for antagonistic activity against V. cholerae and other beneficial properties.Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancerThe use of bacterial spore formers as probiotics.Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.Central venous catheter infection with Bacillus pumilus in an immunocompetent child: a case report.Early murine immune responses from endotracheal exposures to biotechnology-related Bacillus strainsRapid, high-throughput identification of anthrax-causing and emetic Bacillus cereus group genome assemblies using BTyper, a computational tool for virulence-based classification of Bacillus cereus group isolates using nucleotide sequencing dataBiology and taxonomy of Bacillus cereus, Bacillus anthracis, and Bacillus thuringiensis.Probiotic Bacillus cereus Strains, a Potential Risk for Public Health in China.Rapid isolation of gluten-digesting bacteria from human stool and saliva by using gliadin-containing plates.Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseasesOn the physiology and pathophysiology of antimicrobial peptides.Evaluation and Selection of Bacillus Species Based on Enzyme Production, Antimicrobial Activity, and Biofilm Synthesis as Direct-Fed Microbial Candidates for Poultry.Microbial characterization of probiotics--advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC).Bacterial spores as platforms for bioanalytical and biomedical applications.Spore-forming bacteria and their utilisation as probiotics.Physiological Properties and Salmonella Growth Inhibition of Probiotic Bacillus Strains Isolated from Environmental and Poultry Sources.Ileal MUC2 gene expression and microbial population, but not growth performance and immune response, are influenced by in ovo injection of probiotics in broiler chickens.Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives.
P2860
Q24683036-2116A17E-2F9A-4010-80AA-A9A7EAC2929DQ33226168-C88180AF-DB67-4B30-97B7-B2CC33EA83AFQ33785239-43238D64-225F-4D6B-A668-93C02AE489EFQ33838561-A5F0462D-1DBF-4B0F-B5D0-285EEB881BF6Q33926488-84561B67-C7F2-4E4D-8879-9A1105FB7A3DQ34041082-10FB606D-06E4-4561-A11A-F85A207DF549Q34359565-5010E13F-C4DF-4070-8C4B-75A4AD5FCFB1Q34383326-A04354CA-855D-4C97-8E46-0B062D712DF5Q34503589-933EABD9-F470-4393-9FE8-589080AD99F8Q34514299-C82E236B-C841-42FA-A891-B6F4556D7B90Q34684354-1798DF11-4156-4A39-B6E1-6785D5197674Q35044598-CCC37868-89F7-4D6B-AFE7-F8DAC283EA3BQ35689478-F31C1B57-4D75-4531-B221-F88CF73328C6Q35738350-91B59F84-61B8-4706-B6C0-D019F04B7B2BQ35813048-B37C4409-45E6-48A1-96F5-E07B32C54A98Q35833296-B64FB0D0-8A39-4863-B307-6A39D0C9D2C8Q35837401-77639E42-396D-4C63-9451-65F1AF54489AQ35912808-46DED1F1-D6E5-4812-90E3-9BD192CFA522Q35942868-D508CD94-21C5-4D24-BECA-CDA3110BA981Q36039673-69DD1F62-E581-4D70-AABA-6AB5BFF0A69DQ36049714-6D5A9F6A-E9DE-4B01-8BE4-FE1DE1D40181Q36063476-6FDCBC55-089A-4D40-A56D-7C94350F1A64Q36156772-E1F11566-31BD-419A-A356-BD669312DFBDQ36231172-4F13D7BD-B44A-427F-B2D8-41B7A5650B0FQ36295381-314EECC0-EAC5-40EA-86F0-14B3E64DC50DQ36316130-B7C64EEC-0444-49A7-B5D5-52360B2F6DEDQ36317489-1EE8C171-9D3D-49E7-8B51-E331F2836269Q36408539-D78F4683-9894-481F-8123-602BE613426FQ36898728-F89CC599-3C15-4CF3-B47B-303E4969571FQ36924522-EEB60C1B-A4E5-4FBA-83B7-009EDF474048Q37071537-152BF086-E886-4049-9E79-2F384677AD0AQ37123637-8716D0A2-CBB3-4C39-BBAF-E0DA8E57BA24Q37327972-00B31988-5D81-447A-9C6E-96BFEDEBFC85Q37351907-BCD08AE6-32B1-458A-9973-9C9A15B81136Q37542178-BBAB5DA3-EF4E-404D-8769-08877470BD74Q37850353-9BE3D1E1-84FE-4412-B504-ECEEBB42AD11Q37986269-546ADCCB-3B45-4C79-8687-C64E640F3A6AQ38284368-B4728CAB-C822-41A4-A1FD-80667210E902Q38406725-B5E0501F-E857-45EB-AADE-D2318EF6EB83Q38636464-ECBD49FB-F273-45F1-9666-3A26EE6C76B5
P2860
Characterization of Bacillus probiotics available for human use
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of Bacillus probiotics available for human use
@en
Characterization of Bacillus probiotics available for human use.
@nl
type
label
Characterization of Bacillus probiotics available for human use
@en
Characterization of Bacillus probiotics available for human use.
@nl
prefLabel
Characterization of Bacillus probiotics available for human use
@en
Characterization of Bacillus probiotics available for human use.
@nl
P2093
P2860
P1476
Characterization of Bacillus probiotics available for human use
@en
P2093
Adriano O Henriques
Huynh A Hong
Simon M Cutting
Teresa M Barbosa
P2860
P304
P356
10.1128/AEM.70.4.2161-2171.2004
P407
P577
2004-04-01T00:00:00Z